Amarin Corp Est. Q/Q di EPS

Cos'è Est. Q/Q di EPS di Amarin Corp?

Est. Q/Q di EPS di Amarin Corp è -100.00%

Qual è la definizione di Est. Q/Q di EPS?



Il tasso di crescita prospettico trimestrale dell'utile, anno su anno , è l'aumento stimato di EPS di una società per il prossimo trimestre rispetto alla performance di un trimestre precedente.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Est. Q/Q di EPS di aziende nel Health Care settore su NASDAQ rispetto a Amarin Corp

Cosa fa Amarin Corp?

amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.

Aziende con est. q/q di eps simili a Amarin Corp